EPIS® Právní systém | Plné znění

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx pro xxxxx xxxxxxxxxxxx vědeckotechnickému xxxxxxx xxxx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

(Text x&xxxx;xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x&xxxx;xxxxxxx na Smlouvu x&xxxx;xxxxxxxxx Evropské xxxx,

x&xxxx;xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 ze dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí, x&xxxx;xxxxx a zrušení xxxxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (ES) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx xx čl. 37 xxxx.&xxxx;5 xxxxxxxxx nařízení,

vzhledem x&xxxx;xxxxx xxxxxxx:

(1)	Xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 obsahuje xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx xxxxx xx xxxxxxx kritérií xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 přílohy I uvedeného xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx s článkem 37 xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxxx xxxxxx xx zavedení xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx jiných xxxxx. Xxxx, co Xxxxx xxx posuzování xxxxx (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx, xxxxxx x&xxxx;xxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;(2):

—	xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx křemičitým; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx,

—	xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx (ISO), [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx dne 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (XXX); xxxxxxx směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxx (XXX); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N’-kyan-N-methylethanimidamid; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 pro tellur,

—	stanovisko xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx oxid xxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—	xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro daminozid (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—	stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—	xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—	xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 ohledně xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctové xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx a pentadraselných xxxx xx xxxxxx Xxxxxxxx xxxxxx,

—	xxxxxxxxxx ze xxx 17. září 2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro dibutylcín-diacetát,

—	stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—	xxxxxxxxxx xx xxx 17. září 2020 xxx chinoklamin (ISO); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—	xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxx-4-xxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 17. září 2020 xxx xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—	xxxxxxxxxx ze xxx 17. září 2020 xxx 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [x-XXX],

—	xxxxxxxxxx ze xxx 17. září 2020 pro 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—	xxxxxxxxxx ze dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxx,

—	xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 pro 2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; trimethylolpropan-triakrylát,

—	stanovisko ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující &xx;&xxxx;0,1&xxxx;% xxxx. částic s aerodynamickým xxxxxxxx xxxxxx než 50 μx],

—	xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥&xxxx;0,1&xxxx;% xxxx. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx],

—	xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxx xxxxxx,

—	xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro 2,4,6-xxx-xxxx-xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxx (XXX); 2,6-dichlor-4-(3,3-dichlorallyloxy)fenyl{3-[5-(trifluormethyl)-2-pyridyloxy]propyl}ether,

—	stanovisko ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxx-2-xxxxx-1-xxxx, sodnou xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx,

—	xxxxxxxxxx ze xxx 8. října 2020 xxx X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether,

—	stanovisko xx xxx 8. října 2020 xxx 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx A,

—	stanovisko xx xxx 8. října 2020 xxx xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—	xxxxxxxxxx ze dne 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 4,4’-xxxxxxxxxxxxxxx; bisfenol X,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Blue 124,

—	xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx xxxxxxxxxxxxxxxxxx; kyselinu tridekafluorheptanovou,

—	stanovisko xx xxx 10. prosince 2020 xxx methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; xxxxxxxxxxx,

—	xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx soli,

—	stanovisko ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X10-X13, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanovou xxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; xxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxx, xxxxxxxx [x&xxxx;xxxxx rostliny Xxxxxxxxxxx xxxxxx, extrahovaný vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx],

—	xxxxxxxxxx ze dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—	xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx (XXX), 3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid,

—	stanovisko ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 ohledně xxxxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx komise.

(3)

Byly xxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx xx xxxxxxxxxxxx XXX xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx soli; xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxxxx toxicity {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx a jejích pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx na xxxxxx Xxxxxxxx xxxxxx, xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx xxxxxx, xx xxx 10. prosince 2020 xxx xxxx xxxxxxxxx, xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx opětovného xxxxxxxxx xxxxxx informací x&xxxx;xxxxxx xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx komise x&xxxx;xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxx.

(4)

Xxxxxx xxxx xxxxxxxxx informace posoudila x&xxxx;xxxxxxxxxx xx za xxxxxxxxxx x&xxxx;xxxx, aby xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx ve xxxxxxxxxxxx XXX. Na xxxxxxx xxxxxxxxx xxxxxxxxxxx v uvedených xxxxxxxxxxxx je xxxxx xxxxxx zavést, xxxxxxxxxxxx xxxx zrušit harmonizovanou xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx.

(5)

Xxxx, co bylo Xxxxxx xxxxxxx xxxxxxxxxx XXX, xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; pyrogenního xxxxxxxxxxxx xxxxxxxxx oxidu xxxxxxxxxxx x&xxxx;xxxxxxxxx s povrchovou xxxxxxx. Xxxxxxxxxxx silanaminu, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx s povrchovou úpravou xxxx xxxxxx inhalační xxxxxxxx xxxxxxxxx 2, xxxxxxxxxx xx xxxxxxxxxx XXX ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019, by xxxxxx xxx xxxxxxxx xx xxxxxxx XX nařízení (XX) č. 1272/2008, xxxxx Xxxxxx xxxx vědecké xxxxxxxxx posoudila x&xxxx;xxxxxxxxxx, xx by xxxx xxxxx další xxxxxxxxx XXX. Xx přílohy XX nařízení (XX) x.&xxxx;1272/2008 xx xxxx xxxx být xxxxxxxx xxxxxxxxxxx této látky xxxx XXXX RE 2, xxxxxxxxxx xx xxxxxxxxxx xxxxxx XXX xx xxx 5. prosince 2019, xxxxx xxxxxx obdrženy xxxxx xxxx informace, xxxxx by xxxxxxxxxx xxxxx xxxxxxxxx této xxxxxxxxxxx.

(6)	Xxxxxxxx (XX) č. 1272/2008 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx nových xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx nemělo xxx xxxxxxxxxx xxxxx, jelikož xxxxxxxxxx xxxxxxxxx xxxxxxx xxxx na xx, xxx xxxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx látek a směsí xxxxx xxxx aktualizovaným xxxxxxxxxxxx a prodali xxxxxxxxx xxxxxx, xx xxxxx xx xxxxxxxx xxxxxxxxx xxxxxxxxxxx požadavky. Xxxx xxxx xx xxxxxx xxxxxxxx x&xxxx;xxxx, aby xxxxxxxxxx xxxx dostatek xxxx přijmout xxxxxxxx xxxxx x&xxxx;xxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx, xxxxx xxxxxxxx x&xxxx;xxxxxxxx změn provedených xxxxx tohoto nařízení. Xxxxxxxxxxx by však xxxx xxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx klasifikace x&xxxx;xxxxxxxxxxxxx způsobem přizpůsobit xxxxxxxxxx x&xxxx;xxxxxx xx xxxxxxxxxxx základě xxxx xxxxx použitelnosti tohoto xxxxxxxx, aby byla xxxxxxxxx vysoká xxxxxx xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx prostředí x&xxxx;xxx xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 se xxxx x&xxxx;xxxxxxx s přílohou xxxxxx nařízení.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

Toto xxxxxxxx vstupuje x&xxxx;xxxxxxxx xxxxxxxx dnem po xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx unie.

Použije xx xxx xxx 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx xx xxxxxxx xxxxxxxxxxx tohoto xxxxxx xxxxx být xxxxx x&xxxx;xxxxx klasifikovány, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx v platnost.

Xxxx xxxxxxxx xx xxxxxxx v celém rozsahu x&xxxx;xxxxx použitelné xx xxxxx členských státech.

V Bruselu xxx 16.&xxxx;xxxxx 2022.

Za Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX XXX XXXXX

(1)&xxxx;&xxxx;Xx. xxxx. X&xxxx;353, 31.12.2008, s. 1.

(2) Stanoviska jsou xxxxxxxx xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/. – Xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 a ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxxx xx xxxxxxxxxx xxxxxxxxx xx žádost Xxxxxxxx xxxxxx xxxx x&xxxx;xxxxxxxxx xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

XXXXXXX

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 se xxxx takto:

v části 3 xx tabulka 3 xxxx takto:

vkládají xx xxxx xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo CAS	Klasifikace		Označení			Specifické xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX	Xxxxxxxx
Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx ES	Číslo CAS	Xxxx xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx		Xxxxxxxx
„014-052-00-7	xxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx křemičitý x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx	272-697-1	68909-20-6	XXXX RE 2	X373 (xxxxx) (vdechování)	GHS08 Wng	H373 (xxxxx) (xxxxxxxxxx)	XXX066“
„035-005-00-7	xxxxxx xxxxxx	235-183-8	12124-97-9	Xxxx. 1X Xxxx. XXXX XX 3 XXXX XX 1 Xxx Xxxxx. 2	X360XX X362 X336 X372 (nervový xxxxxx) X319	XXX08 XXX07 Xxx	X360XX X362 X336 X372 (xxxxxxx xxxxxx) X319“
„050-032-00-4	xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx)	220-481-2	2781-10-4	Xxxx. 2 Repr. 1X XXXX XX 1	X341 X360XX X372 (xxxxxxxx xxxxxx)	XXX08 Xxx	X341 X360XX X372 (xxxxxxxx xxxxxx)“
„050-033-00-X	xxxxxxxxxx-xxxxxxxx	213-928-8	1067-33-0	Xxxx. 2 Repr. 1X XXXX XX 1	H341 H360FD H372 (xxxxxxxx xxxxxx)	XXX08 Xxx	X341 X360XX X372 (xxxxxxxx xxxxxx)“
„052-001-00-0	xxxxxx	236-813-4	13494-80-9	Xxxx. 1X Xxxx.	X360Xx X362	XXX08 Xxx	X360Xx X362“
„052-002-00-6	xxxx telluričitý	231-193-1	7446-07-3	Repr. 1X Xxxx.	X360Xx X362	XXX08 Xxx	X360Xx X362“
„056-005-00-3	xxxxxxxxx xxxxxxx-xxxxxxxx	237-222-4	13701-59-2	Xxxx. 1X Xxxxx Xxx. 4 Xxxxx Xxx. 3	X360XX X332 X301	XXX08 XXX06 Xxx	X360XX X332 X301		xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx) xxxxxx: XXX&xxxx;= 100&xxxx;xx/xx TH“
„601-097-00-8	propylbenzen	203-132-9	103-65-1	Flam. Xxx. 3 Xxx. Xxx. 1 XXXX XX 3 Aquatic Xxxxxxx 2	X226 X304 X335 X411	XXX02 XXX08 XXX07 XXX09 Xxx	X226 X304 X335 X411“
„603-243-00-6	xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx	253-057-0	36483-57-5; 1522-92-5	Xxxx. 1X Xxxx. 2	X350 X341	XXX08 Xxx	X350 X341“
„604-096-00-0	xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-butoxyethoxy)ethoxy]methyl}-6-propyl-1,3-benzodioxol	200-076-7	51-03-6	STOT XX 3 Eye Xxxxx. 2 Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X335 X319 X400 X410	XXX07 XXX09 Xxx	X335 X319 X410	XXX066	X&xxxx;= 1 X&xxxx;= 1“
„604-097-00-6	2,4,6-xxx-xxxx-xxxxxxxxxx	211-989-5	732-26-3	Xxxx. 1X Xxxxx Tox. 4 XXXX RE 2 Xxxx Xxxx. 1X	X360X X302 X373 (xxxxx) X317	XXX08 XXX07 Xxx	X360X X302 X373 (xxxxx) X317		xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx TH“
„604-098-00-1	4,4’-sulfonyldifenol; xxxxxxxx X	201-250-5	80-09-1	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„606-153-00-5	xxxxxxxxxx	204-337-6	119-61-9	Xxxx. 1X	X350	XXX08 Xxx	X350“
„606-154-00-0	xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx	220-529-2	2797-51-5	Xxxx. 2 Xxxx. 2 Acute Tox. 4 XXXX XX 2 Eye Xxxxx. 2 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X361x X302 X373 (xxxxxx xxxx, xxxxxxx) X319 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X361x X302 X373 (krevní xxxx, xxxxxxx) X319 X317 X410		xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„607-756-00-6	xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx	227-561-6	5888-33-5	Xxxx Sens. 1&xxxx;X	X317	XXX07 Xxx	X317“
„607-757-00-1	xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx	216-485-9	1596-84-5	Xxxx. 2	X351	XXX08 Xxx	X351“
„607-758-00-7	4,4′-xxxxx(xxxxxxxxxxxxxxxxxxxxx)	201-286-1	80-51-3	Xxxx-xxxxx. X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H242 H400 H410	GHS02 GHS09 Dgr	H242 H410		M = 1 M = 1“
„607-759-00-2	xxxxxx-4-xxxxxxxxxxxxxxx	216-407-3	1576-35-8	Xxxx-xxxxx. D	H242	GHS02 Dgr	H242“
„607-760-00-8	2-{N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino}ethyl-acetát; X.X. Xxxxxxxx Xxxx 124	239-203-6	15141-18-1	Xxxx Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317		Xxxx Sens. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“
„607-761-00-3	xxxxxxxxxxxxxxxxx xxxxxxxx; tridekafluorheptanová kyselina	206-798-9	375-85-9	Repr. 1X XXXX XX 1	X360X X372 (xxxxx)	XXX08 Xxx	X360X X372 (játra)“
„607-762-00-9	methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; valifenalát	-	283159-90-0	Carc. 2 Xxxxxxx Xxxxxxx 2	X351 X411	XXX08 XXX09 Xxx	X351 X411“
„607-763-00-4	6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx	-	-	Xxxx. 1X Xxx Irrit. 2	X360XX X319	XXX08 XXX07 Xxx	X360XX X319“
„607-764-00-X	6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx	-	2156592-54-8	Xxxx. 1X Xxx Irrit. 2	X360XX X319	XXX08 XXX07 Xxx	X360XX X319“
„607-765-00-5	6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina	-	-	Repr. 1X	X360XX	XXX08 Xxx	X360XX“
„613-341-00-0	xxxxxxxxxxx (XXX); 3,6-bis(o-chlorfenyl)-1,2,4,5-tetrazin	277-728-2	74115-24-5	Aquatic Xxxxxxx 1	X410	XXX09 Xxx	X410		X&xxxx;= 1“
„613-342-00-6	xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx	200-385-7	58-55-9	Xxxx. 1B	H360D	GHS08 Dgr	H360D“
„613-343-00-1	pyridalyl (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx	-	179101-81-6	Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X317 X400 X410	XXX07 XXX09 Xxx	X317 X410		X&xxxx;= 1 000 M = 100“
„613-344-00-7	pyridin-2-thiol-1-oxid, xxxxx xxx; xxxxx xxx xxxxxxxxxx; pyrithion xxxxx	223-296-5; 240-062-8	3811-73-2; 15922-78-8	Xxxxx Xxx. 3 Xxxxx Xxx. 3 Xxxxx Xxx. 4 XXXX XX 1 Xxxx Xxxxx. 2 Eye Xxxxx. 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 2	X331 X311 X302 X372 (xxxxxxx xxxxxx) X315 X319 X317 X400 X411	XXX06 XXX08 XXX09 Xxx	X331 X311 X302 X372 (xxxxxxx xxxxxx) X315 X319 X317 X410	XXX070	xxxxxxxxx: XXX&xxxx;= 0,5 mg/l (xxxxx xxxx xxxx) xxxxxxxx: XXX&xxxx;= 790&xxxx;xx/xx TH orální: ATE = 500&xxxx;xx/xx XX X&xxxx;= 100“
„613-345-00-2	1,3,5-xxxxxxx-2,4,6-xxxxxxx; xxxxxxx	203-615-4	108-78-1	Xxxx. 2 XXXX XX 2	H351 H373 (xxxxxx xxxxx)	XXX08 Xxx	X351 X373 (močové xxxxx)“
„615-046-00-2	1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]	220-474-4	2778-42-9	Xxxx. Sens. 1 Xxxx Xxxx. 1&xxxx;X	X334 X317	XXX08 Xxx	X334 X317“
„615-047-00-8	1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [x-XXX]	222-852-4	3634-83-1	Xxxx. Xxxx. 1 Xxxx Sens. 1&xxxx;X	X334 X317	XXX08 Xxx	X334 X317		Xxxx Xxxx. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“
„615-048-00-3	2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx	218-485-4	2162-73-4	Xxxx. Xxxx. 1 Xxxx Xxxx. 1	H334 H317	GHS08 Dgr	H334 H317“
„615-049-00-9	1,5-diisokyanatonaftalen [obsahující &xx;&xxxx;0,1&xxxx;% hmot. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μm]	221-641-4	3173-72-6	STOT XX 3 Skin Irrit. 2 Xxx Irrit. 2 Xxxx. Xxxx. 1 Xxxx Sens. 1&xxxx;X Xxxxxxx Xxxxxxx 3	X335 X315 X319 X334 X317 X412	XXX07 XXX08 Xxx	X335 X315 X319 X334 X317 X412“
„615-050-00-4	1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]	221-641-4	3173-72-6	Xxxxx Xxx. 2 STOT XX 3 Xxxx Xxxxx. 2 Xxx Xxxxx. 2 Xxxx. Xxxx. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxxxx 3	X330 X335 X315 X319 X334 X317 X412	XXX06 XXX08 Xxx	X330 X335 X315 X319 X334 X317 X412		xxxxxxxxx: XXX&xxxx;= 0,27 mg/l (xxxxx nebo xxxx)“
„616-237-00-3	xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx	-	239110-15-7	Xxxx. 2	H361d	GHS08 Wng	H361d“
„616-238-00-9	triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx	477-690-9	874819-71-3	Xxxx. 1X XXXX XX 2	X360Xx X373 (ledviny)	GHS08 Dgr	H360Fd H373 (xxxxxxx)“
„616-239-00-4	X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx	-	1255734-28-1	Xxxx. 2 Xxxxx Xxx. 4 Skin Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H361f H332 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H361f H332 H317 H410		inhalační: ATE = 2,2&xxxx;xx/x (xxxxx xxxx xxxx) X&xxxx;= 10 X&xxxx;= 1“
„616-240-00-X	xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx a 3-(difluormethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaftalen-5-yl]pyrazol-4-karboxamid [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], isopyrazam	-	881685-58-1	Carc. 2 Xxxx. 1B Skin Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X360X X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X360X X317 X410		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;% X&xxxx;= 10 X&xxxx;= 10“
„650-058-00-1	Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx organickými xxxxxxxxxxxx]	283-644-7	84696-25-3	Xxxx. 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxxxx 1	X361x X317 X410	XXX08 XXX07 XXX09 Xxx	X361x X317 X410		X&xxxx;= 10“

xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx xxxxxx položkami:

Indexové xxxxx	Xxxxxxxx název	Číslo ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX	Xxxxxxxx
Indexové xxxxx	Xxxxxxxx název	Číslo ES	Číslo XXX	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx doplň. xxxxxxxxxxxx xxx o nebezpečnosti		Xxxxxxxx
„014-001-00-9	trichlorsilan	233-042-5	10025-78-2	Flam. Liq. 1 Xxxxx-xxxxx. 1 Xxxxx Xxx. 3 Xxxxx Xxx. 4 Xxxx Xxxx. 1 A Eye Xxx. 1	X224 X260 X331 X302 X314 X318	XXX02 XXX06 XXX05 Xxx	X224 X260 X331 X302 X314	XXX014 XXX029 XXX071	xxxxxxxxx: XXX&xxxx;= 7,6 mg/l (páry) orální: ATE = 1&xxxx;000 mg/kg XX“
„023-001-00-8	xxxx xxxxxxxxx	215-239-8	1314-62-1	Xxxx. 2 Carc. 1X Xxxx. 2 Xxxx. Xxxxx Xxx. 3 Acute Xxx. 2 XXXX XX 3 XXXX RE 1 Xxxxxxx Xxxxxxx 2	X341 X350 X361xx X362 X301 X330 X335 X372 (xxxxxxx xxxxx, xxxxxxxxxx) X411	XXX06 XXX08 XXX09 Xxx	X341 X350 X361xx X362 X301 X330 X335 X372 (xxxxxxx xxxxx, xxxxxxxxxx) X411		xxxxxxxxx: XXX&xxxx;= 0,05&xxxx;xx/x (xxxxx nebo mlha) orální: ATE = 220&xxxx;xx/xx XX“
„601-024-00-X	xxxxx	202-704-5	98-82-8	Xxxx. Xxx. 3 Xxxx. 1X Xxx. Xxx. 1 XXXX XX 3 Xxxxxxx Xxxxxxx 2	X226 X350 X304 X335 X411	XXX02 XXX08 XXX07 XXX09 Xxx	X226 X350 X304 X335 X411“
„603-014-00-0	2-xxxxxxxxxxx-1-xx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxx	203-905-0	111-76-2	Xxxxx Xxx. 3 Xxxxx Xxx. 4 Xxxx Xxxxx. 2 Eye Xxxxx. 2	X331 X302 X315 X319	XXX06 Xxx	X331 X302 X315 X319		xxxxxxxxx: XXX&xxxx;= 3&xxxx;xx/x (xxxx) xxxxxx: XXX&xxxx;= 1&xxxx;200 &xxxx;xx/xx XX“
„603-107-00-6	2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	203-906-6	111-77-3	Xxxx. 1X	X360X	XXX08 Xxx	X360X		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%“
„604-030-00-0	4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx A	201-245-8	80-05-7	Repr. 1X XXXX XX 3 Eye Dam. 1 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X335 X318 X317 X400 X410	XXX08 XXX07 XXX05 XXX09 Xxx	X360X X335 X318 X317 X410		X&xxxx;= 1 M = 10“
„607-111-00-9	2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx	239-701-3	15625-89-5	Xxxx. 2 Xxxx Xxxxx. 2 Xxx Xxxxx. 2 Skin Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	X351 X315 X319 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X315 X319 X317 X410		X&xxxx;= 1 X&xxxx;= 1	X“
„607-230-00-6	2-xxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx soli, x&xxxx;xxxxxxxx xxxx, xxxxx jsou xxxxxxx xxxxx x&xxxx;xxxx xxxxxxx	-	-	Xxxx. 1B	H360D	GHS08 Dgr	H360D“
„607-253-00-1	cyfluthrin (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx	269-855-7	68359-37-5	Xxxx. Xxxxx Xxx. 2 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H362 H330 H300 H370 (xxxxxxx xxxxxx) X400 X410	XXX06 XXX08 XXX09 Xxx	X362 X330 X300 X370 (xxxxxxx systém) H410		inhalační: ATE = 0,14&xxxx;xx/x (xxxxx xxxx xxxx) xxxxxx: XXX&xxxx;= 14 mg/kg XX X&xxxx;= 1&xxxx;000&xxxx;000 X&xxxx;= 1 000 000 “
„607-254-00-7	β-xxxxxxxxxx (XXX); reakční směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx a rel-(R)-kyan(4-fluor-3-fenoxyfenyl)methyl-(1S,3R)-3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropan-1-karboxylát	-	1820573-27-0	Lact. Acute Tox. 2 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H362 H330 H300 H370 (xxxxxxx xxxxxx) X400 X410	XXX06 XXX08 XXX09 Xxx	X362 X330 X300 X370 (xxxxxxx xxxxxx) X410		xxxxxxxxx: XXX&xxxx;= 0,081 mg/l (xxxxx xxxx mlha) orální: ATE = 11&xxxx;xx/xx XX X&xxxx;= 1&xxxx;000&xxxx;000 X&xxxx;= 1 000 000 “
„607-734-00-6	xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx	404-290-3	7216-95-7	Xxxx. 1B Acute Xxx. 4 STOT XX 2 Xxx Xxxxx. 2	X360X X332 X373 (xxxxxxxxxx) X319	XXX08 XXX07 Xxx	X360X X332 X373 (xxxxxxxxxx) X319		Xxxx. 1X; X360X: C ≥ 3 % inhalační: ATE = 1,5 mg/l (xxxxx xxxx xxxx)“
„607-735-00-1	{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx	200-652-8	67-43-6	Xxxx. 1X Xxxxx Tox. 4 XXXX XX 2 Eye Xxxxx. 2	X360X X332 X373 (vdechování) H319	GHS08 GHS07 Dgr	H360D H332 H373 (xxxxxxxxxx) X319		Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;% xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“
„607-736-00-7	xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]	205-391-3	140-01-2	Xxxx. 1X Xxxxx Xxx. 4 STOT RE 2	X360X X332 X373 (xxxxxxxxxx)	XXX08 XXX07 Xxx	X360X X332 X373 (xxxxxxxxxx)		Xxxx. 1X; H360D: X&xxxx;≥&xxxx;3&xxxx;% xxxxxxxxx: XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx nebo xxxx)“
„608-032-00-2	xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx	-	135410-20-7&xxxx;160430-64-8	Xxxx. 2 Acute Tox. 3 Xxxxxxx Xxxxxxx 1 Xxxxxxx Xxxxx 1	X361x X301 X410 X400	XXX08 XXX06 XXX09 Xxx	X361x X301 X410		xxxxxx: XXX&xxxx;= 140&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„609-042-00-X	xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx	254-938-2	40487-42-1	Xxxx. 2 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X361x X400 X410	XXX08 XXX09 Xxx	X361x X410		X&xxxx;= 100 M = 10“
„613-012-00-1	xxxxxxxx (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx	246-585-8	25057-89-0	Xxxx. 2 Acute Xxx. 4 Xxx Irrit. 2 Xxxx Xxxx. 1	X361x X302 X319 X317	XXX08 XXX07 Xxx	X361x X302 X319 X317		xxxxxx: XXX&xxxx;= 1&xxxx;600 &xxxx;xx/xx XX“
„616-164-00-7	xxxxxxxxxxxxx (ISO); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx		149961-52-4	Xxxx. 2 Xxxx. 2 Acute Xxx. 4 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H361d H332 H400 H410	GHS08 GHS07 GHS09 Wng	H351 H361d H332 H410		inhalační: ATE = 1,3&xxxx;xx/x (prach nebo xxxx) X&xxxx;= 100 M = 100“

x)	xxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx 615-007-00-X xx xxxxxxx.

Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx pro xxxxx xxxxxxxxxxxx vědeckotechnickému xxxxxxx xxxx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

Xxxxxx&xxxx;1

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

XXXXXXX

Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

ze xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx pro xxxxx xxxxxxxxxxxx vědeckotechnickému xxxxxxx xxxx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí

Xxxxxx&xxxx;1

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

XXXXXXX

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.